{"id":"W4366754870","doi":"10.1016/j.conctc.2023.101143","title":"Anticoagulation in type 2 myocardial infarctions: Lessons learned from the rivaroxaban in type 2 myocardial infarctions feasibility trial","year":2023,"lang":"en","type":"article","venue":"Contemporary Clinical Trials Communications","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"Canadian Cardiovascular Society","keywords":"Medicine; Myocardial infarction; Rivaroxaban; Clinical trial; Population; Placebo; Troponin; Internal medicine; Retrospective cohort study; Intensive care medicine; Physical therapy; Cardiology; Pathology; Alternative medicine; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05483568,0.0007703166,0.003114706,0.0007769972,0.0004710661,0.00337407,0.00151151,0.003268693,0.004247059],"category_scores_gemma":[0.0907476,0.0005023539,0.002389064,0.001654434,0.0009630563,0.003079956,0.001416055,0.005552453,0.000835812],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006004002,"about_ca_system_score_gemma":0.003639265,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008550073,"about_ca_topic_score_gemma":0.001987498,"domain_scores_codex":[0.9706451,0.02391022,0.002085327,0.0006847636,0.002114569,0.0005600298],"domain_scores_gemma":[0.9340357,0.05047766,0.00556063,0.003352042,0.00370237,0.002871633],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.08870027,0.003379708,0.03823974,0.0104394,0.006829893,0.001586481,0.001901944,0.002138165,0.001139782,0.01003331,0.1094819,0.7261294],"study_design_scores_gemma":[0.3359938,0.05595378,0.152119,0.05599739,0.01953361,0.003980379,0.002472085,0.01059028,0.001654701,0.06134619,0.2995669,0.0007919213],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.2608522,0.3115963,0.01325411,0.3658952,0.01191487,0.005060411,0.006482288,0.000252033,0.02469267],"genre_scores_gemma":[0.587396,0.2265584,0.05107025,0.0808062,0.02893999,0.01285614,0.006825557,0.0003463738,0.00520105],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.05483568,"threshold_uncertainty_score":0.2900023,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.765640505794616,"score_gpt":0.5657367087481037,"score_spread":0.1999037970465123,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}